Device type · OBO
Tomography, Optical Coherence
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OBO
Ophthalmic
Device class
Class II
FDA decisions since 2015
45
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Tomography, Optical Coherence
- Product code
- OBO
- Device class
- Class II
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.1570
- Specialty
- Ophthalmology
- FDA record
- Classification database entry for OBO
Latest FDA decisions
The 8 newest of 45 since 2015.
- ANTERION510(k)
K261019 · Decided Sep 11, 2026 · 168 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K253837 · Decided May 7, 2026 · 157 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- UNITY DX (UDX)510(k)
K252633 · Decided Dec 23, 2025 · 125 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K250553 · Decided Jul 18, 2025 · 143 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K250868 · Decided May 12, 2025 · 49 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- Anterion510(k)
K240924 · Decided Dec 13, 2024 · 253 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K241163 · Decided Oct 11, 2024 · 168 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K241081 · Decided Jul 17, 2024 · 89 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 2 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 2 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 2 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3215-2026 · Started Aug 6, 2026 · Posted by FDA Sep 18, 2026
Reason given: Wheels may come loose when module is being pushed or pulled during movement or transportation, affecting stability of the stand. The stand may tip over as a result. Falling stand may cause impact or crushing injuries, particularly to the feet, legs, hands or arms of the operator or nearby persons.
Cause as FDA categorized it: Component design/selection
- CIRRUS HD-OCT, Models 5000 AngioPlex and 6000 AngioPlexOpen, Classified
Z-0723-2022 · Started Jan 14, 2022
Reason given: Optic nerve head angiography scan to be turned off due to its distribution without pre-market clearance.
Cause as FDA categorized it: No Marketing Application
- OCT-Camera 211 01 A3; Running software iOCT-Control 3 v1.4Open, Classified
Z-0478-2022 · Started Nov 3, 2021
Reason given: Malfunction of the automatic laser beam shut-off, the OCT unit might not recognize whether the laser beam is safely switched off
Cause as FDA categorized it: Software design (manufacturing process)
- Chassis Label - "CIRRUS HD-OCT Rx-Only" Product Label Exterior RX - "CIRRUS HD-OCT Model 6000"Open, Classified
Z-2227-2021 · Started Jul 8, 2021
Reason given: Due to failure to acquire pre-market clearance for its high resolution tomographic/biomicroscope imaging device (Model 6000) prior to commercializing the device.
Cause as FDA categorized it: No Marketing Application
- SPECTRALIS with HEYEX2 image management system. a non-contact ophthalmic diagnostic imaging device.Terminated
Z-2437-2019 · Started Jul 3, 2019
Reason given: Error in the default configuration which could lead to the incorrect display of patient master data.
Cause as FDA categorized it: Under Investigation by firm
Z-0770-2020 · Started Oct 16, 2018
Reason given: Under certain fault conditions, the existing design may expose the operator to a hazardous voltage when contacting the metal enclosure (including mounting screws) around the up/down switch.
Cause as FDA categorized it: Device Design
Z-1535-2018 · Started Dec 8, 2017
Reason given: FDA notified Heidelberg Engineering that a 510(k) clearance is needed for the SPECTRALIS Widefield OCT feature, and, on November 27, 2017, Heidelberg Engineering submitted a new 510(k) for this feature. FDA has asked Heidelberg Engineering to instruct customers not to use the Widefield OCT software feature on the...
Cause as FDA categorized it: No Marketing Application
Z-0024-2013 · Started Sep 7, 2012 · Posted by FDA Oct 9, 2012
Reason given: Devices labeled for an intended use not included in the existing 510(k) or PMA. Specifically, "The Retina" poster provided with the systems, and the book "RETINAL OCT Analysis and Interpretation Method" by Bruno Lumbroso and Marco Rispoli which are not labeled within 51O(k) cleared product description.
Cause as FDA categorized it: No Marketing Application
Showing the 8 newest of 12 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.